Guocai Zhong

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

mBio

Microbiology spectrum

Nature chemical biology

Nature biotechnology

Scripps Florida

Harbin Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Scripps Florida Sep 16 2013 - Jun 29 2018

United States

Research Asssociate :: Infectious Diseases

National Institute of Biological Sciences

China

Postdoctoral research fellow

Education History

Harbin Medical University

China

PHD :: Microbiology

Harbin Medical University

China

BSC

Publications

Weitong Yao, Yujun Li, Danting Ma, Xudong Hou, Haimin Wang, Xiaojuan Tang, Dechun Cheng, He Zhang, Chengzhi Du, Hong Pan, Chao Li, Hua Lin, Mengsi Sun, Qiang Ding, Yingjie Wang, Jiali Gao, Guocai Zhong
Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs. Microbiology spectrum (2023)
Wenlin Ren, Yu Zhang, Juhong Rao, Ziyi Wang, Jun Lan, Kunpeng Liu, Xuekai Zhang, Xue Hu, Chen Yang, Guocai Zhong, Rong Zhang, Xinquan Wang, Chao Shan, Qiang Ding
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant. mBio (2023)
Mengjia Lu, Weitong Yao, Yujun Li, Danting Ma, Zhaoyong Zhang, Haimin Wang, Xiaojuan Tang, Yanqun Wang, Chao Li, Dechun Cheng, Hua Lin, Yandong Yin, Jin-Cun Zhao, Guocai Zhong
Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection. Microbiology spectrum (2023)
Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quan-Xin Long, Devin J Kenney, Aoife K O'Connell, Yu Zhang, Jin Zhong, Guocai Zhong, Florian Douam, Xinquan Wang, Ailong Huang, Rong Zhang, Qiang Ding
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. mBio 13 (2) (2022)
Zhaoyong Zhang, Eric Zeng, Lu Zhang, Weiming Wang, Yingkang Jin, Jiye Sun, Shuxiang Huang, Wenguang Yin, Jun Dai, Zhen Zhuang, Zhao Chen, Jing Sun, Airu Zhu, Fang Li, Weitao Cao, Xiaobo Li, Yongxia Shi, Mian Gan, Shengnan Zhang, Peilan Wei, Jicheng Huang, Nanshan Zhong, Guocai Zhong, Jingxian Zhao, Yanqun Wang, Weihui Shao, Jincun Zhao
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo. Cell discovery 7 (1) (2021)
Yujun Li, Haimin Wang, Xiaojuan Tang, Shisong Fang, Danting Ma, Chengzhi Du, Yifei Wang, Hong Pan, Weitong Yao, Renli Zhang, Xuan Zou, Jie Zheng, Liangde Xu, Michael Farzan, Guocai Zhong
SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig. Journal of virology 94 (22) (2020)
Guocai Zhong, Haimin Wang, Wenhui He, Yujun Li, Huihui Mou, Zachary J Tickner, Mai H Tran, Tianling Ou, Yiming Yin, Huitian Diao, Michael Farzan
A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo. Nature biotechnology 38 (2) (2019)
Guocai Zhong, Haimin Wang, Yujun Li, Mai H Tran, Michael Farzan
Cpf1 proteins excise CRISPR RNAs from mRNA transcripts in mammalian cells. Nature chemical biology 13 (8) (2017)

Guocai Zhong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guocai Zhong